Sesardic T. Bioassays for evaluation of medical products derived from bacterial toxins.
Curr Opin Microbiol 2012;
15:310-6. [PMID:
22651974 DOI:
10.1016/j.mib.2012.05.008]
[Citation(s) in RCA: 11] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2012] [Accepted: 05/14/2012] [Indexed: 12/14/2022]
Abstract
Bioassays play central role in evaluation of biological products and those derived from bacterial toxins often rely exclusively on in vivo models for assurance of safety and potency. This chapter reviews existing regulatory approved methods designed to provide information on potency and safety of complex biological medicines with an insight into strategies considered for alternative procedures.
Collapse